gs-5816 and Hepatitis

gs-5816 has been researched along with Hepatitis* in 1 studies

Other Studies

1 other study(ies) available for gs-5816 and Hepatitis

Article	Year
Biochemical Basis of Vosevi, a New Treatment for Hepatitis C Biochemistry, 2018, 02-06, Volume: 57, Issue:5 Topics: Aminoisobutyric Acids; Antiviral Agents; Carbamates; Cyclopropanes; Drug Combinations; Hepacivirus; Hepatitis; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Proline; Quinoxalines; Serine Proteases; Sofosbuvir; Sulfonamides; Viral Nonstructural Proteins	2018

Article

Year

Biochemical Basis of Vosevi, a New Treatment for Hepatitis C

Biochemistry, 2018, 02-06, Volume: 57, Issue:5

Topics: Aminoisobutyric Acids; Antiviral Agents; Carbamates; Cyclopropanes; Drug Combinations; Hepacivirus; Hepatitis; Heterocyclic Compounds, 4 or More Rings; Humans; Lactams, Macrocyclic; Leucine; Macrocyclic Compounds; Proline; Quinoxalines; Serine Proteases; Sofosbuvir; Sulfonamides; Viral Nonstructural Proteins

2018